Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Glaukos Corporation Common Stock
(NY:
GKOS
)
102.68
-5.07 (-4.71%)
Streaming Delayed Price
Updated: 1:37 PM EDT, Mar 27, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Glaukos Corporation Common Stock
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Benzinga's Top Ratings Upgrades, Downgrades For July 12, 2022
↗
July 12, 2022
Upgrades
Via
Benzinga
Glaukos Announces Participation in the William Blair Growth Stock Conference
June 02, 2022
From
Glaukos Corporation
Via
Business Wire
Glaukos: Q4 Earnings Insights
↗
February 22, 2022
Glaukos (NYSE:GKOS) reported its Q4 earnings results on Tuesday, February 22, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Glaukos...
Via
Benzinga
Earnings Scheduled For February 22, 2022
↗
February 22, 2022
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is projected to report quarterly earnings at $0.13 per share on revenue of $439.63 million. • Sohu...
Via
Benzinga
Analyst Ratings For Glaukos
↗
January 19, 2022
Glaukos (NYSE:GKOS) has observed the following analyst ratings within the las...
Via
Benzinga
Glaukos Announces Participation in the Piper Sandler Virtual Ophthalmology Symposium
May 20, 2022
From
Glaukos Corporation
Via
Business Wire
Glaukos Corporation Announces First Quarter 2022 Financial Results
May 04, 2022
From
Glaukos Corporation
Via
Business Wire
Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2022 American Society of Cataract and Refractive Surgery Annual Meeting
April 21, 2022
From
Glaukos Corporation
Via
Business Wire
Glaukos Announces the Release of its 2021 Sustainability Report
April 20, 2022
From
Glaukos Corporation
Via
Business Wire
Glaukos to Release First Quarter 2022 Financial Results after Market Close on May 4
April 13, 2022
From
Glaukos Corporation
Via
Business Wire
Sight Sciences' Q4 Earnings, FY22 Guidance Beat Street View
↗
March 25, 2022
Sight Sciences Inc (NASDAQ: SGHT) has treated the first patient in the TRIDENT trial evaluating OMNI Surgical System compared to Glaukos Corp's (NYSE...
Via
Benzinga
Glaukos Announces Commencement of Phase 2 Corneal Health Clinical Program for Third-Generation iLink™ Therapy
March 14, 2022
From
Glaukos Corporation
Via
Business Wire
Glaukos Corporation Announces Fourth Quarter and Full Year 2021 Financial Results
February 22, 2022
From
Glaukos Corporation
Via
Business Wire
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
↗
February 20, 2022
Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries. On the regulatory front...
Via
Benzinga
Glaukos Announces Executive Leadership Changes
February 07, 2022
From
Glaukos Corporation
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For February 3, 2022
↗
February 03, 2022
Upgrades BTIG upgraded the previous rating for Insulet Corp (NASDAQ:PODD) from Neutral to Buy. For the third quarter, Insulet had an EPS of $0.18, compared to year-ago...
Via
Benzinga
Glaukos Corporation to Release Fourth Quarter and Full Year 2021 Financial Results after Market Close on February 22
February 01, 2022
From
Glaukos Corporation
Via
Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
↗
January 12, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 19, 2022
↗
January 19, 2022
Upgrades For Rocket Companies Inc (NYSE:RKT), JP Mo...
Via
Benzinga
The Daily Biotech Pulse: Biogen Slumps As CMS Announces Restrictive Coverage For Aduhelm, Aclaris CMO Departs, Immuron Spikes On US Military Award
↗
January 12, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Biogen Shares Slip On Restricted Coverage For Its Alzheimer's Drug Biogen...
Via
Benzinga
Glaukos' iDose TR Shows Sustained Reduction In Ocular Pressure, Favorable Safety Profile
↗
January 12, 2022
Ophthalmic medical company Glaukos Corporation (NYSE: GKOS) announced data from the Phase 2b trial of iDose TR, a sustained-release travoprost implant. The...
Via
Benzinga
Glaukos Announces First Patient Enrolled in Phase 2 Clinical Trial for Presbyopia
January 11, 2022
From
Glaukos Corporation
Via
Business Wire
Glaukos Announces First Patient Enrolled in Phase 2 Clinical Trial for Dry Eye Disease
January 11, 2022
From
Glaukos Corporation
Via
Business Wire
Glaukos’ iDose® TR Demonstrates Sustained IOP Reduction and Favorable Safety Profile Over 36 Months in Phase 2b Study
January 11, 2022
From
Glaukos Corporation
Via
Business Wire
The Daily Biotech Pulse: Glaukos Gets FDA Nod, Neurocrine Preannounces Soft Ingrezza Sales, 3 IPOs
↗
January 07, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Hepion's Lead NASH Drug Candidate Gets The Non-Proprietary Name...
Via
Benzinga
A Peek Into The Markets: US Stock Futures Higher; All Eyes On Jobs Report
↗
January 07, 2022
Pre-open movers U.S. stock futures traded higher in early pre-market trade ahead of the key jobs data for December. Investors are awaiting earnings results from Acuity Brands,...
Via
Benzinga
5 Stocks To Watch For January 7, 2022
↗
January 07, 2022
Some of the stocks that may grab investor focus today are: Wall Street expects Acuity Brands, Inc. (NYSE: AYI) to report quarterly earnings at $2.41 per share on revenue of $...
Via
Benzinga
Glaukos Announces FDA 510(k) Clearance of iPRIME™
January 06, 2022
From
Glaukos Corporation
Via
Business Wire
Glaukos Announces Participation in the J.P. Morgan Healthcare Conference
December 29, 2021
From
Glaukos Corporation
Via
Business Wire
Glaukos Announces Retirement of William J. Link, Ph.D., as Chairman of the Board and Election of Thomas W. Burns as New Chairman and Mark J. Foley as Lead Independent Director
December 20, 2021
From
Glaukos Corporation
Via
Business Wire
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
